Halal Pharma Stock : Biocon Gets U.S. FDA Approval for Cancer-Treating Antibody Jobevne™
Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has received approval from the U.S. FDA for Jobevne™, a biosimilar to Avastin®, used in the treatment of various cancers. The approval marks a major step forward in the company’s oncology biosimilar strategy in the U.S., reinforcing its position as a leading player in the global biosimilars … Read more